These findings demonstrate an indispensable role for AXL in facilitating SARS‐CoV‐2 infection, suggesting combination treatments comprised of ACE2 and AXL inhibitors may be potentially efficacious therapeutic solutions for COVID‐19. Here, AXL is linked to COVID-19.